Skip to content

Levomenol

Drug profile

Also known as: (-)-alpha-Bisabolol, bisabolol, kamillosan

FDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Levomenol is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including CHRNA7 and STAT3.

  • Molecular targets: CHRNA7 and STAT3 (2 listed in DrugCentral).
  • Molecular formula: C15H26O; molecular weight 222.37 g/mol.

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Neuronal acetylcholine receptor subunit alpha-7CHRNA7unknownIC50 5.51
Signal transducer and activator of transcription 3STAT3unknownIC50 4.14

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

Chemical structure

Molecular formulaC15H26O
Molecular weight222.37 g/mol
CAS number—
InChIKeyRGZSQWQPBWRIAQ-CABCVRRESA-N
PubChem CID442343
CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Levomenol work?

Its molecular targets in DrugCentral include CHRNA7 and STAT3.

What is the chemical formula of Levomenol?

Levomenol has the molecular formula C15H26O and a molecular weight of 222.37 g/mol.

Browse: all drugs starting with L · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets2
Indications0
FormulaC15H26O
DrugCentral ID4619
Interactive profile